220 related articles for article (PubMed ID: 27010381)
1. Hepatocellular Carcinoma within Milan Criteria: No-Touch Multibipolar Radiofrequency Ablation for Treatment-Long-term Results.
Seror O; N'Kontchou G; Nault JC; Rabahi Y; Nahon P; Ganne-Carrié N; Grando V; Zentar N; Beaugrand M; Trinchet JC; Diallo A; Sellier N
Radiology; 2016 Aug; 280(2):611-21. PubMed ID: 27010381
[TBL] [Abstract][Full Text] [Related]
2. Radiofrequency ablation using a multiple-electrode switching system for hepatocellular carcinoma within the Milan criteria: long-term results.
Tan Y; Jiang J; Wang Q; Guo S; Ma K; Bie P
Int J Hyperthermia; 2018 May; 34(3):298-305. PubMed ID: 28554226
[TBL] [Abstract][Full Text] [Related]
3. Safety and Efficacy of Irreversible Electroporation for the Treatment of Hepatocellular Carcinoma Not Amenable to Thermal Ablation Techniques: A Retrospective Single-Center Case Series.
Sutter O; Calvo J; N'Kontchou G; Nault JC; Ourabia R; Nahon P; Ganne-Carrié N; Bourcier V; Zentar N; Bouhafs F; Sellier N; Diallo A; Seror O
Radiology; 2017 Sep; 284(3):877-886. PubMed ID: 28453431
[TBL] [Abstract][Full Text] [Related]
4. Thermal Injury-induced Hepatic Parenchymal Hypoperfusion: Risk of Hepatocellular Carcinoma Recurrence after Radiofrequency Ablation.
Lee DH; Lee JM; Yoon JH; Kim YJ; Han JK
Radiology; 2017 Mar; 282(3):880-891. PubMed ID: 27643670
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
Wu J; Chen MH; Yang W; Wu W; Yan K
Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
[TBL] [Abstract][Full Text] [Related]
6. No-Touch Multi-bipolar Radiofrequency Ablation for the Treatment of Subcapsular Hepatocellular Carcinoma ≤ 5 cm Not Puncturable via the Non-tumorous Liver Parenchyma.
Petit A; Hocquelet A; N'kontchou G; Varin E; Sellier N; Seror O; Sutter O
Cardiovasc Intervent Radiol; 2020 Feb; 43(2):273-283. PubMed ID: 31673728
[TBL] [Abstract][Full Text] [Related]
7. Radiofrequency ablation of hepatocellular carcinoma: long-term results and prognostic factors in 235 Western patients with cirrhosis.
N'Kontchou G; Mahamoudi A; Aout M; Ganne-Carrié N; Grando V; Coderc E; Vicaut E; Trinchet JC; Sellier N; Beaugrand M; Seror O
Hepatology; 2009 Nov; 50(5):1475-83. PubMed ID: 19731239
[TBL] [Abstract][Full Text] [Related]
8. Radiofrequency ablation of hepatocellular carcinoma as first-line treatment: long-term results and prognostic factors in 162 patients with cirrhosis.
Lee DH; Lee JM; Lee JY; Kim SH; Yoon JH; Kim YJ; Han JK; Choi BI
Radiology; 2014 Mar; 270(3):900-9. PubMed ID: 24475823
[TBL] [Abstract][Full Text] [Related]
9. Radiofrequency ablation for intrahepatic recurrent hepatocellular carcinoma: long-term results and prognostic factors in 168 patients with cirrhosis.
Lee DH; Lee JM; Lee JY; Kim SH; Han JK; Choi BI
Cardiovasc Intervent Radiol; 2014 Jun; 37(3):705-15. PubMed ID: 23912493
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of radiofrequency ablation as first-line therapy for hepatocellular carcinoma less than 3 cm in potentially transplantable patients.
Doyle A; Gorgen A; Muaddi H; Aravinthan AD; Issachar A; Mironov O; Zhang W; Kachura J; Beecroft R; Cleary SP; Ghanekar A; Greig PD; McGilvray ID; Selzner M; Cattral MS; Grant DR; Lilly LB; Selzner N; Renner EL; Sherman M; Sapisochin G
J Hepatol; 2019 May; 70(5):866-873. PubMed ID: 30615906
[TBL] [Abstract][Full Text] [Related]
11. Ten-year survival of hepatocellular carcinoma patients undergoing radiofrequency ablation as a first-line treatment.
Yang W; Yan K; Goldberg SN; Ahmed M; Lee JC; Wu W; Zhang ZY; Wang S; Chen MH
World J Gastroenterol; 2016 Mar; 22(10):2993-3005. PubMed ID: 26973395
[TBL] [Abstract][Full Text] [Related]
12. Radiofrequency ablation of hepatocellular carcinoma in difficult locations: Strategies and long-term outcomes.
Yang W; Yan K; Wu GX; Wu W; Fu Y; Lee JC; Zhang ZY; Wang S; Chen MH
World J Gastroenterol; 2015 Feb; 21(5):1554-66. PubMed ID: 25663774
[TBL] [Abstract][Full Text] [Related]
13. No-touch multibipolar radiofrequency ablation vs. surgical resection for solitary hepatocellular carcinoma ranging from 2 to 5 cm.
Mohkam K; Dumont PN; Manichon AF; Jouvet JC; Boussel L; Merle P; Ducerf C; Lesurtel M; Rode A; Mabrut JY
J Hepatol; 2018 Jun; 68(6):1172-1180. PubMed ID: 29410287
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous radiofrequency ablation for early hepatocellular carcinoma: risk factors for survival.
Kikuchi L; Menezes M; Chagas AL; Tani CM; Alencar RS; Diniz MA; Alves VA; D'Albuquerque LA; Carrilho FJ
World J Gastroenterol; 2014 Feb; 20(6):1585-93. PubMed ID: 24587635
[TBL] [Abstract][Full Text] [Related]
15. [Long term (5 years) outcome of radiofrequency ablation for hepatocellular carcinoma in 256 cases].
Chen MH; Yan K; Yang W; Gao W; Dai Y; Huo L; Zhang H; Huang XF
Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Dec; 37(6):671-2. PubMed ID: 16378128
[TBL] [Abstract][Full Text] [Related]
16. Rate of local tumor progression following radiofrequency ablation of pathologically early hepatocellular carcinoma.
Hao Y; Numata K; Ishii T; Fukuda H; Maeda S; Nakano M; Tanaka K
World J Gastroenterol; 2017 May; 23(17):3111-3121. PubMed ID: 28533668
[TBL] [Abstract][Full Text] [Related]
17. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation.
Lencioni R; Cioni D; Crocetti L; Franchini C; Pina CD; Lera J; Bartolozzi C
Radiology; 2005 Mar; 234(3):961-7. PubMed ID: 15665226
[TBL] [Abstract][Full Text] [Related]
18. Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy.
Takahashi S; Kudo M; Chung H; Inoue T; Ishikawa E; Kitai S; Tatsumi C; Ueda T; Minami Y; Ueshima K; Haji S
Oncology; 2007; 72 Suppl 1():98-103. PubMed ID: 18087189
[TBL] [Abstract][Full Text] [Related]
19. Comparison of no-touch multi-bipolar vs. monopolar radiofrequency ablation for small HCC.
Hocquelet A; Aubé C; Rode A; Cartier V; Sutter O; Manichon AF; Boursier J; N'kontchou G; Merle P; Blanc JF; Trillaud H; Seror O
J Hepatol; 2017 Jan; 66(1):67-74. PubMed ID: 27422750
[TBL] [Abstract][Full Text] [Related]
20. Downstaging disease in patients with hepatocellular carcinoma outside of Milan criteria: strategies using drug-eluting bead chemoembolization.
Green TJ; Rochon PJ; Chang S; Ray CE; Winston H; Ruef R; Kreidler SM; Glueck DH; Shulman BC; Brown AC; Durham J
J Vasc Interv Radiol; 2013 Nov; 24(11):1613-22. PubMed ID: 24060436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
